hexvix 85 mg, powder and solvent for intravesical solution
ipsen pharmaceuticals limited - hexaminolevulinate hydrochloride - pdr+solv/soln/intravesical use - 85 milligram(s) - other diagnostic agents
idrolax 10 grams powder for oral solution
ipsen limited - macrogol 4000 - powder for oral solution - 10 grams - osmotically acting laxatives
somatuline la 30mg, powder and solvent for prolonged-release suspension for injection
ipsen pharmaceuticals limited - lanreotide - powder and solvent for suspension for injection - 30 milligram(s) - somatostatin and analogues; lanreotide
hexvix 85mg, powder and solvent for intravesical solution
ipsen m.e.p.e ag. dimitriou 63 alimos, 17456 athens, greece - hexaminolevulinate - powder and solvent for solution for intravesical use - hexaminolevulinate 85 mg - diagnostic agents
salvacyl, 11.25 mg powder and solvent for prolonged-release suspension for injection
ipsen pharmaceuticals limited - triptorelin - powder and solvent for prolonged-release suspension for injection - 11.25 milligram(s) - gonadotropin releasing hormone analogues; triptorelin
diphereline triptorelin (as embonate) 22.5 mg powder for suspension vial and water for injections ampoule
ipsen pty ltd - triptorelin embonate, quantity: 31 mg (equivalent: triptorelin, qty 22.5 mg) - suspension, powder for - excipient ingredients: polyglactin; carmellose sodium; polysorbate 80; mannitol - diphereline is indicated for the treatment of hormone-dependent locally advanced or metastatic prostate cancer.,diphereline 22.5mg 6 month formulation only:,diphereline 22.5 mg is indicated for the treatment of children 2 years and older with central precocious puberty (cpp).
diphereline triptorelin {as embonate} 11.25mg powder for suspension vial and water for injections ampoule
ipsen pty ltd - triptorelin embonate, quantity: 19.32 mg - injection, diluent for - excipient ingredients: water for injections - diphereline is indicated for the treatment of hormone-dependent locally advanced or metastatic prostate cancer.
diphereline triptorelin (as embonate) 3.75 mg powder for suspension vial and water for injections ampoule
ipsen pty ltd - triptorelin embonate, quantity: 5.6 mg (equivalent: triptorelin, qty 3.75 mg) - injection, diluent for - excipient ingredients: water for injections - diphereline is indicated for the treatment of hormone-dependent locally advanced or metastatic prostate cancer.
decapeptyl sr 3mg powder and solvent for suspension for injection vials
ipsen ltd - triptorelin acetate - powder and solvent for suspension for injection - 3mg
somatuline la 30mg powder and solvent for suspension for injection vials
ipsen ltd - lanreotide acetate - powder and solvent for suspension for injection - 30mg